Please select your page
  • Slide
  • Slide
  • Slide


CERENIS KasteleinJohn J.P. Kastelein, M.D., Ph.D.
Professor of Medicine, Strategic Chair of Genetics of Cardiovascular Disease, and Chairman of the Department of Vascular Medicine at the Academic Medical Center of the University of Amsterdam

Professor Kastelein is Chair of the National Scientific Committee on Familial Hypercholesterolemia (EHC), a member of the Royal Dutch Society for Medicine & Physics, a member of the Council for Basic Science of the American Heart Association and the European Atherosclerosis Society, a Boardmember of the International Task Force for CHD Prevention, a member of the Executive Board of the International Atherosclerosis Society (IAS), and a principal investigator of the Bloodomics and CardioGenics consortia.
Professor Kastelein’s current research interests are in hypertriglyceridaemia, hypercholesterolaemia and low-HDL cholesterol, all conditions associated with atherosclerosis and cardiovascular disease. In 1995, Professor Kastelein set up StoeH Foundation and currently holds a position on its Board of Directors. Since its inception, StoeH has diagnosed over 12,000 individuals with familial hypercholesterolaemia (FH).
He has published over 570 research papers in peer-reviewed journals and recently developed the use of non-invasive B-mode ultrasound studies of the carotid arteries for the diagnosis and assessment of novel treatments for atherosclerosis. The Academic Medical Centre in Amsterdam (AMC) is the global leader in this technique, now exported to many sites throughout Europe.
Professor Kastelein received his medical degree and internal medicine training in Amsterdam in the 1980s.




Cerenis Therapeutics Holding SA
33-43 av. Georges Pompidou – Bât. D2
31130 Balma – France
Tel. +33 5 62 24 97 06
Fax +33 5 61 57 34 12


Cerenis Therapeutics Inc
PO Box 861
Lakeland, MI 48143